OSE Pharma SA (OSE) - Total Liabilities

Latest as of June 2025: €53.58 Million EUR ≈ $62.64 Million USD

Based on the latest financial reports, OSE Pharma SA (OSE) has total liabilities worth €53.58 Million EUR (≈ $62.64 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

OSE Pharma SA - Total Liabilities Trend (2012–2024)

This chart illustrates how OSE Pharma SA's total liabilities have evolved over time, based on quarterly financial data. See OSE Pharma SA (OSE) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

OSE Pharma SA Competitors by Total Liabilities

The table below lists competitors of OSE Pharma SA ranked by their total liabilities.

Company	Country	Total Liabilities
Fine DNC Co. Ltd KQ:049120	Korea	₩53.07 Billion
Forsys Metals Corp. TO:FSY	Canada	CA$358.54K
Kino Indonesia Tbk PT JK:KINO	Indonesia	Rp2.81 Trillion
Dye & Durham Ltd TO:DND	Canada	CA$1.54 Billion
Wonik Corporation KQ:032940	Korea	₩95.59 Billion
Global Lithium Resources Ltd AU:GL1	Australia	AU$3.47 Million
Power Metals Corp V:PWM	Canada	CA$1.94 Million
Transart Graphics Co Ltd TW:8481	Taiwan	NT$212.56 Million

Liability Composition Analysis (2012–2024)

This chart breaks down OSE Pharma SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OSE stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.87	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.74	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how OSE Pharma SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for OSE Pharma SA (2012–2024)

The table below shows the annual total liabilities of OSE Pharma SA from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	€60.15 Million ≈ $70.32 Million	+1.81%
2023-12-31	€59.08 Million ≈ $69.07 Million	-0.07%
2022-12-31	€59.12 Million ≈ $69.12 Million	+9.52%
2021-12-31	€53.99 Million ≈ $63.12 Million	+51.61%
2020-12-31	€35.61 Million ≈ $41.63 Million	+17.15%
2019-12-31	€30.40 Million ≈ $35.54 Million	+100.65%
2018-12-31	€15.15 Million ≈ $17.71 Million	-30.85%
2017-12-31	€21.91 Million ≈ $25.61 Million	-12.45%
2016-12-31	€25.02 Million ≈ $29.25 Million	+893.33%
2015-12-31	€2.52 Million ≈ $2.94 Million	-9.49%
2014-12-31	€2.78 Million ≈ $3.25 Million	+131.92%
2013-12-31	€1.20 Million ≈ $1.40 Million	+31.15%
2012-12-31	€915.00K ≈ $1.07 Million	--

About OSE Pharma SA

PA:OSE France Biotechnology

Market Cap

$91.53 Million

€78.29 Million EUR

Market Cap Rank

#19731 Global

#302 in France

Share Price

€3.49

Change (1 day)

-2.57%

52-Week Range

€3.02 - €7.20

All Time High

€15.00